2022年版醫保藥(yao)(yao)品目(mu)(mu)錄(lu)顯(xian)示，目(mu)(mu)前中國共(gong)收(shou)載西藥(yao)(yao)和中成藥(yao)(yao)達2967種(zhong)，其中西藥(yao)(yao)1586種(zhong)，中成藥(yao)(yao)1381種(zhong)。中藥(yao)(yao)飲(yin)片未(wei)作調整(zheng)，仍為892種(zhong)。此次共(gong)111個(ge)藥(yao)(yao)品新增進(jin)入(ru)目(mu)(mu)錄(lu)，3個(ge)藥(yao)(yao)品被調出目(mu)(mu)錄(lu)。

本次調(diao)整新(xin)增(zeng)的111個藥(yao)品名單里(li)，其(qi)中(zhong)(zhong)西(xi)藥(yao)類有(you)(you)3種(zhong)、協(xie)議(yi)期內(nei)談判藥(yao)品部(bu)分 (一)西(xi)藥(yao)類有(you)(you)83種(zhong)、協(xie)議(yi)期內(nei)談判藥(yao)品部(bu)分 (二)中(zhong)(zhong)成藥(yao)類有(you)(you)8種(zhong)，競價藥(yao)品部(bu)分有(you)(you)17種(zhong)。

2022醫保(bao)談判目(mu)錄新增(zeng)的74個(ge)(ge)談判藥(yao)(yao)品涉及21個(ge)(ge)臨床(chuang)組別，其中(zhong)罕見病(bing)用(yong)(yong)藥(yao)(yao)7種(zhong)(zhong)，新冠肺炎(yan)治療用(yong)(yong)藥(yao)(yao)2種(zhong)(zhong)，其他(ta)領(ling)域(yu)用(yong)(yong)藥(yao)(yao)12種(zhong)(zhong)，腫瘤用(yong)(yong)藥(yao)(yao)18種(zhong)(zhong)，丙肝、艾滋病(bing)等抗毒感染用(yong)(yong)藥(yao)(yao)15種(zhong)(zhong)，高(gao)血(xue)壓、糖尿病(bing)、高(gao)血(xue)脂(zhi)等慢(man)性病(bing)用(yong)(yong)藥(yao)(yao)20種(zhong)(zhong)。